OrderlyMeds

Provider Profile Name: OrderlyMeds
Website: orderlymeds.com
Founded: January 2024
Headquarters: Decatur, Georgia
Provider Type: Telehealth — Virtual Only, Direct-to-Consumer

Operating Details

• Fully virtual — online health screening, licensed provider review, home delivery
• Medical screening provided through partner Beluga Health
• Exclusively 503A pharmacy partners: SmartPharmaRx, Casa, and PerfectRx/PerfectionRx — all named publicly on the website
• Available in all 50 states
• No insurance accepted for compounded medications; HSA/FSA eligible; brand-name options may use insurance
• No membership fees — all-inclusive pricing covers consultation, medication, syringes, and shipping
• Injectable medications only — no oral GLP-1 formulations
• CMO: Dr. Spears, with background in emergency medicine and hormone/peptide therapy
• Weekly check-in and weight monitoring via text-based support

Approach OrderlyMeds is a 100% online platform that connects patients to licensed healthcare professionals in all 50 states, with providers who can recommend personalized treatment plans including prescription GLP-1 medications if appropriate, delivered straight to the door — with all-inclusive pricing covering online visits, medication, direct access to providers through secure messaging, and over $3,700 in partnership perks and expert-led resources.

About the Company

OrderlyMeds is a telehealth-based weight loss platform founded in January 2024 and headquartered in Decatur, Georgia, offering both compounded and brand-name GLP-1 medications and positioning itself as one of the more affordable entry points in the market.

The platform is young by the standards of this review series — founded just over two years ago — but has built a substantial customer base and review footprint quickly, driven largely by its aggressive pricing on the compounded semaglutide starter plan.

Dr. Spears, the CMO, brings a background in emergency medicine and clinical research in hormone and peptide therapy — providing board-certified oversight with a focus on evidence-based guidance and long-term health outcomes rather than simply prescription volume. The publicly named CMO is a meaningful transparency positive in a space where most platforms do not identify their chief medical officer.

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

OrderlyMeds publicly names all three of its pharmacy partners — SmartPharmaRx, Casa, and PerfectRx/PerfectionRx — on the website and states that each batch of medication undergoes rigorous testing for sterility and potency before it reaches the patient. This level of pharmacy disclosure is rare in the compounded GLP-1 telehealth market and allows patients to independently verify pharmacy licensure before their first order.

GLP-1 Offerings and Weight Loss Services

OrderlyMeds offers a focused, injection-only medication menu — no oral GLP-1 alternatives:

Compounded Semaglutide (GLP-1 injectable):

• Weekly subcutaneous injection
• SimpleStart 3-month introductory plan for new patients beginning at the lowest dosage; ongoing monthly refills thereafter

Compounded Tirzepatide (GLP-1/GIP injectable):

• Weekly subcutaneous injection
• Same SimpleStart introductory structure as semaglutide

Brand-Name Options:

• Zepbound (tirzepatide) and Wegovy (semaglutide) — available for patients who prefer FDA-approved medications

Included in all compounded plans:

• Provider consultation, prescription, syringes, shipping — plus onboarding webinars, videos, and access to partnership perks including fitness and wellness resources
• Weekly text-based check-ins and weight monitoring
• Direct provider access via secure messaging

Pricing — and What Reviewers Say

OrderlyMeds uses a SimpleStart introductory model followed by ongoing monthly pricing:

Compounded Semaglutide:

• SimpleStart: $224 for 3 months (approximately $74/month effective) — all three months ship at once at the lowest dose
• Ongoing monthly: $149/month
• Returning patient 3-month plan: $335 (25% discount)

Compounded Tirzepatide:

• SimpleStart: $449 for 3 months (approximately $149/month effective)
• Ongoing monthly: $299/month
• Returning patient 3-month plan: $670 (25% discount)

Brand-Name:

• Wegovy: $1,839/month; Zepbound: $1,498/month

The semaglutide starter plan at $224 for three months — bringing the effective starting cost to approximately $74 per month — is among the most affordable all-inclusive entry points in the compounded GLP-1 space, undercutting most competitors.

What reviewers say about pricing: Customers consistently praise the transparent, no-hidden-fees pricing structure — with multiple reviewers calling out OrderlyMeds specifically for not inflating price with unnecessary add-ons compared to competitors, citing the $249 starter plan as delivering strong value. One reviewer noted they would stay with OrderlyMeds even if they could save $50/month elsewhere, based on trust and consistency.

Reviews from Trustpilot and Google

OrderlyMeds has 463 Trustpilot reviews at time of writing — a meaningful if modest pool for a platform founded in early 2024.

What patients praise:

• Customer service quality is the most consistent positive — reviewers frequently describe compassionate, responsive, and proactive support staff who follow up without being prompted
• Weekly check-in and weight monitoring via text are cited as differentiators that create a more personal experience than purely transactional platforms
• Fast onboarding and prescription approval, typically within 24–48 hours per company FAQ
• Cold-packed delivery with temperature-controlled packaging praised by multiple reviewers

Common complaints:

Beyond-Use Date (BUD) controversy — the most significant documented concern: The most distinctive concern with OrderlyMeds is a recurring pattern of patients receiving medications with expired or extended beyond-use dates. Multiple Trustpilot and BBB reviewers report receiving vials past their original BUD, accompanied by a new sticker or letter claiming the date has been extended based on stability testing. OrderlyMeds states their pharmacy partner conducted FDA-approved laboratory testing confirming safety up to 365 days for semaglutide and 300 days for tirzepatide from compounding, but customers find this practice confusing and concerning. This issue is worth flagging directly with OrderlyMeds before ordering — patients should ask specifically about the BUD policy and request documentation of the stability testing methodology.

Shipping delays: Shipping delays are a significant documented issue — while the website states 5–7 business days, multiple reviewers in January 2026 reported waits of two to six weeks, with orders not processing for days after payment.

Other complaints include inconsistent follow-through after payment and isolated reports of aggressive automated re-marketing contact after a negative review.

Compounding Pharmacies Used

OrderlyMeds exclusively works with 503A pharmacies based in the United States: SmartPharmaRx, Casa, and PerfectRx/PerfectionRx — all named publicly. All pharmacy partners are 503A designated, meaning they prepare patient-specific prescriptions and must adhere to USP standards and specific sections of the Federal Food, Drug and Cosmetic Act. Patients should ask which specific pharmacy will fulfill their prescription and confirm that pharmacy’s current licensure status before ordering.

Note: OrderlyMeds’ compounded semaglutide starter pricing ($224 for three months) is among the lowest all-inclusive rates in this review series, and the public disclosure of all three pharmacy partners — SmartPharmaRx, Casa, and PerfectRx/PerfectionRx — is a meaningful transparency positive. The platform’s most significant documented concern is the beyond-use date extension practice: patients have received medications with extended BUDs accompanied by company letters citing stability testing. This practice is not inherently unsafe if the underlying testing is legitimate, but patients should ask for documentation of that testing before accepting extended-BUD medication. Shipping delays in early 2026 are also a documented pattern. Compounded medications are not FDA-approved. Always consult a licensed medical provider before beginning any GLP-1 program.